117 related articles for article (PubMed ID: 36227250)
41. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.
Selvam C; Jachak SM; Thilagavathi R; Chakraborti AK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1793-7. PubMed ID: 15780608
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles.
Ranatunge RR; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Young DV; Zemetseva IS
Bioorg Med Chem; 2004 Mar; 12(6):1357-66. PubMed ID: 15018908
[TBL] [Abstract][Full Text] [Related]
43. Water mediated construction of trisubstituted pyrazoles/isoxazoles library using ketene dithioacetals.
Savant MM; Pansuriya AM; Bhuva CV; Kapuriya N; Patel AS; Audichya VB; Pipaliya PV; Naliapara YT
J Comb Chem; 2010; 12(1):176-80. PubMed ID: 19950975
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of indomethacin analogs possessing a N-difluoromethyl-1,2-dihydropyrid-2-one ring system: a search for novel cyclooxygenase and lipoxygenase inhibitors.
Chowdhury MA; Huang Z; Abdellatif KR; Dong Y; Yu G; Velázquez CA; Knaus EE
Bioorg Med Chem Lett; 2010 Oct; 20(19):5776-80. PubMed ID: 20727750
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase.
Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC.
Elshemy HAH; Abdelall EKA; Azouz AA; Moawad A; Ali WAM; Safwat NM
Eur J Med Chem; 2017 Feb; 127():10-21. PubMed ID: 28038322
[TBL] [Abstract][Full Text] [Related]
48. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476
[TBL] [Abstract][Full Text] [Related]
49. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS
Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
[TBL] [Abstract][Full Text] [Related]
53. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
Balaji NV; HariBabu B; Rao VU; Subbaraju GV; Nagasree KP; Kumar MMK
Curr Top Med Chem; 2019; 19(9):662-682. PubMed ID: 30834836
[TBL] [Abstract][Full Text] [Related]
55. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations.
Thangarasu P; Manikandan A; Thamaraiselvi S
Bioorg Chem; 2019 May; 86():410-419. PubMed ID: 30769266
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
[TBL] [Abstract][Full Text] [Related]
57. Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability.
Pati ML; Vitale P; Ferorelli S; Iaselli M; Miciaccia M; Boccarelli A; Di Mauro GD; Fortuna CG; Souza Domingos TF; Rodrigues Pereira da Silva LC; de Pádula M; Cabral LM; Sathler PC; Vacca A; Scilimati A; Perrone MG
Eur J Med Chem; 2019 Feb; 164():59-76. PubMed ID: 30590258
[TBL] [Abstract][Full Text] [Related]
58. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.
Neelarapu R; Holzle DL; Velaparthi S; Bai H; Brunsteiner M; Blond SY; Petukhov PA
J Med Chem; 2011 Jul; 54(13):4350-64. PubMed ID: 21548582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
